RET gene mutations spectrum in patients with medullary thyroid carcinoma (MTC) from Great Poland region

被引：0
|
作者：
Marta Kaczmarek-Ryś
Katarzyna Ziemnicka
Bartłomiej Budny
Małgorzata Szkudlarek
Szymon Hryhorowicz
Marzena Skrzypczak-Zielińska
Andrzej Pławski
机构：
[1] Polish Academy of Sciences,Institute of Human Genetics
[2] University of Medical Sciences,The Department of Endocrinology, Metabolism and Internal Diseases
[3] Adam Mickiewicz University,The NanoBioMedical Center
来源：
Hereditary Cancer in Clinical Practice | / 13卷 / Suppl 2期
关键词：
Primary Hyperparathyroidism; Medullary Thyroid Carcinoma; Multiple Endocrine Neoplasia; Transmembrane Receptor Tyrosine Kinase; Familial Medullary Thyroid Carcinoma;
D O I：
10.1186/1897-4287-13-S2-A12
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Germline Mutations of RET in Korean Patients with Medullary Thyroid Cancer
    Chun, S.
    Lee, W.
    Bae, M.
    Kim, S.
    Kim, T.
    Kim, W.
    Shong, Y.
    Hong, S.
    Min, W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 640 - 640
  • [22] Efficacy of cabozantinib (Cabo) in medullary thyroid cancer (MTC) patients with RAS or RET mutations: Results from a phase III study
    Sherman, Steven I.
    Cohen, Ezra E. W.
    Schoffski, Patrick
    Elisei, Rossella
    Schlumberger, Martin
    Wirth, Lori J.
    Mangeshkar, Milan
    Aftab, Dana T.
    Clary, Douglas O.
    Brose, Marcia S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma
    Marsh, DJ
    Learoyd, DL
    Andrew, SD
    Krishnan, L
    Pojer, R
    Richardson, AL
    Delbridge, L
    Eng, C
    Robinson, BG
    CLINICAL ENDOCRINOLOGY, 1996, 44 (03) : 249 - 257
  • [24] Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?
    Hansen, HS
    Torring, H
    Godballe, C
    Jäger, AC
    Nielsen, FC
    CANCER, 2000, 89 (04) : 863 - 867
  • [25] Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma
    Wohllk, N
    Cote, GJ
    Bugalho, MMJ
    Ordonez, N
    Evans, DB
    Goepfert, H
    Khorana, S
    Schultz, P
    Richards, CS
    Gagel, RF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10): : 3740 - 3745
  • [26] RET oncogene mutations in a large Korean kindred with familial medullary thyroid carcinoma
    Lee, Y.
    Park, H.
    Jung, J.
    Lim, Y.
    Uchino, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan
    Kameyama, K
    Okinaga, H
    Takami, H
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (6-7) : 345 - 347
  • [28] RET and RAS Mutations in Medullary Thyroid Carcinoma (MTC) and Their Impact on Histologic Grade, Tumor Characteristics, and Clinical Outcome: An International Multicentric Study of 289 Patients
    Xu, Bin
    Viswanathan, Kartik
    Lubin, Daniel
    Fuchs, Talia
    Alzumaili, Bayan
    Bani, Mohamed Amine
    Behrman, David
    de Biase, Dario
    Chou, Angela
    De Leo, Antonio
    Dogan, Snjezana
    Magliocca, Kelly
    Maloberti, Thais
    Mohanty, Abhinita
    Scoazec, Jean-Yves
    Shi, Qiuying
    Untch, Brian
    Ganly, Ian
    Barletta, Justine
    Al Ghuzlan, Abir
    Gill, Anthony
    Tallini, Giovanni
    Ghossein, Ronald
    LABORATORY INVESTIGATION, 2023, 103 (03) : S509 - S510
  • [29] Utilization of Genetic Testing for RET Mutations in Patients with Medullary Thyroid Carcinoma: a Single-Center Experience
    Parkhurst, Emily
    Calonico, Elise
    Abboy, Sridevi
    JOURNAL OF GENETIC COUNSELING, 2018, 27 (06) : 1411 - 1416
  • [30] Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations
    Miyauchi, A
    Matsuzuka, F
    Hirai, K
    Yokozawa, T
    Kobayashi, K
    Ito, Y
    Nakano, K
    Kuma, K
    Futami, H
    Yamaguchi, K
    WORLD JOURNAL OF SURGERY, 2002, 26 (08) : 1023 - 1028
12345